Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Breast cancer PDxO cultures for drug discovery and functional precision oncology

STAR Protocols(2023)10.1016/j.xpro.2023.102402Source: DataRank Database

Breast cancer PDxO cultures for drug discovery and functional precision oncology is a research paper published in STAR Protocols (2023). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

gen uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 1.29)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Ling Zhao ORCID,Andrew Butterfield ORCID,Chieh‐Hsiang Yang,Emilio Cortes-Sanchez,Katrin P. Guillen

Live enrichment

PubMed:37402170 PMC:PMC10339058 OpenAlex:https://openalex.org/W4383032083

National Cancer Institute

Grant: U54CA224076

National Cancer Institute

Grant: U01CA217617

NIH

Grant: P30CA042014

DOD

Grant: W81XWH1410417

DOD

Grant: W81XWH1210077

National Institutes of Health

Grant: 3P30CA042014-30S2

Cancer Center Support Grant

National Institutes of Health

Grant: 5U01CA217617-02

Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance

National Institutes of Health

Grant: 3U54CA224076-01S2

PDX Trial Center for Breast Cancer Therapy

Huntsman Cancer Foundation

University of Utah

Breast Cancer Research Foundation

California Breast Cancer Research Program

FWCI

1.29

Citation Percentile

0.8%

Citation Trend

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.xpro.2023.102402

publisherhttps://doi.org/10.1016/j.xpro.2023.102402

publisherhttps://api.elsevier.com/content/article/PII:S2666166723003696?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166723003696?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37402170

Fields of Study

3D Printing in Biomedical ResearchCancer Cells and MetastasisCell Image Analysis Techniques03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsBreast NeoplasmsDrug Evaluation, PreclinicalFemaleHumansMiceDrug DiscoveryPrecision Medicine

Keywords

Precision oncologyClinical OncologyDrugOncologyMedicineIn vivoProtocol (science)Breast cancerDrug discoveryAnticancer drugDrug responseCancerPrecision medicineInternal medicineComputational biologyMedical physicsBioinformaticsPharmacologyBiologyPathologyAlternative medicineCell cultureOrganoidsModel OrganismsCell-based AssaysScience (General)Drug Evaluation, PreclinicalCorrectionBreast NeoplasmsQ1-390MiceProtocolHumansAnimalsFemale

Breast cancer PDxO cultures for drug discovery and functional precision oncology

FAIR Checklist

Authors (8)

Funding (12 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)